DNA X Inc
SONM
16 hedge funds and large institutions have $912K invested in DNA X Inc in 2023 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 4 increasing their positions, 3 reducing their positions, and 2 closing their positions.
150% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 2
33% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 3
23% more funds holding
Funds holding: 13 → 16 (+3)
0.01% less ownership
Funds ownership: 0.03% → 0.02% (-0.01%)
63% less capital invested
Capital invested by funds: $2.43M → $912K (-$1.52M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SA
Sicart Associates
New York
|
+$149K |
| 2 |
FFA
First Foundation Advisors
Irvine,
California
|
+$37.2K |
| 3 |
Millennium Management
New York
|
+$31.5K |
| 4 |
State Street
Boston,
Massachusetts
|
+$14.9K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$13K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EI
EAM Investors
Solana Beach,
California
|
-$1.17M |
| 2 |
Renaissance Technologies
New York
|
-$89K |
| 3 |
Bank of New York Mellon
New York
|
-$4.46K |
| 4 |
Northern Trust
Chicago,
Illinois
|
-$1.95K |
| 5 |
BlackRock
New York
|
-$977 |
SONM Hedge Fund Activity: Q3 2023 in Review
16 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in DNA X Inc (SONM) for Q3 2023, worth a combined $912K — down 63% from $2.43M a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new SONM positions and 2 closed out — a net gain of 3 holders — while 4 added to existing stakes and 3 trimmed.
The largest buyer was Sicart Associates, adding an estimated $149K. The largest seller was EAM Investors, exiting entirely with an estimated $1.17M sold.
- 16 institutional investors held DNA X Inc (SONM) as of Q3 2023, up from 13 in Q2 2023.
- Funds reported $912K of DNA X Inc stock for Q3 2023, down 63% quarter-over-quarter.
- 5 funds opened new DNA X Inc positions in Q3 2023 and 2 closed out, a net change of +3 holders.
- The largest DNA X Inc buyer in Q3 2023 was Sicart Associates, an estimated $149K added.
- The largest DNA X Inc seller in Q3 2023 was EAM Investors, an estimated $1.17M sold.
Based on aggregated 13F filings for Q3 2023.